Cost-effectiveness Analysis of Temozolomide Combined with Radiotherapy in the Treatment of Glioblasto-ma
- VernacularTitle:替莫唑胺联合放疗治疗胶质母细胞瘤的成本-效果分析
- Author:
Peipei RONG
;
Jia LIU
;
Jinchun SONG
;
Yue WU
;
Jing FENG
- Publication Type:Journal Article
- Keywords:
Temozolomide;
Glioblastoma;
Cost-effective analysis
- From:
China Pharmacist
2015;(8):1338-1340
- CountryChina
- Language:Chinese
-
Abstract:
To study the cost-effectiveness of temozolomide combined with radiotherapy in the treatment of glioblasto-ma. Methods:According to the clinical trial data, cost-effectiveness and sensitivity of the results was analyzed based on the domestic cost and consumption level. Results:Temozolomide combined with radiotherapy could prolong one month of overall survival with the additional cost of RMB 58 959. 7 yuan in each case when compared with radiotherapy alone. Conclusion:Temozolomide combined with radiotherapy has no advantage on cost-effectiveness when compared with radiotherapy alone.
